High density of CD68+/CD163+ tumour‐associated macrophages (M2‐TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B‐cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|2|110-112

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.2, 2015-06, pp. : 110-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP

By  

Current Cancer Drug Targets, Vol. 14, Iss. 7, 2014-09 ,pp. : 659-670

Bentham Science Publishers

Access to resources Recommend Favorite

Novel agents for diffuse large B-cell lymphoma

By Sinha Rajni   DeJoubner Nutan   Flowers Christopher  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 669-680

Informa Healthcare

Access to resources Recommend Favorite

Azathioprine: Diffuse large B-cell lymphoma associated with Epstein-Barr virus in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1343, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Ophthalmoplegia with Diffuse Large B Cell Lymphoma: Vital Differential Diagnosis

By Muzammil S   Kreze OD  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 930-932

Field House Publishing

Access to resources Recommend Favorite

Age-related differences in quality of life among patients with diffuse large B-cell lymphoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2857-2858

Blackwell Publishing

Access to resources Recommend Favorite